Improving cardiometabolic and blood pressure health in Detroit through early prevention
Official title: Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
Run by Wayne State University · NCT06593496 · Data updated 2026-11-12
This project will follow adults seen at Wayne Health mobile units who have elevated blood pressure to see if tracking their care, sending text reminders, and offering home monitoring helps improve blood pressure control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Wayne State University Academic / other |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | June 11, 2025 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2028 |
| Registry record updated | July 15, 2025 |
| Trial ID | NCT06593496 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who attended Wayne Health Mobile Unit events in Detroit with systolic ≥120 or diastolic ≥80, who have a phone that can receive text messages, and who consent to ongoing follow-up and EHR review.
✕Probably not a fit
People with normal blood pressure (<120/<80), pregnant individuals, children under 18, those without a text-capable phone, those unable to consent, or those enrolled in another mobile-unit interventional trial are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
ACHIEVE P1-EPI is the prospective observational component of the ACHIEVE GREATER Center focused on patients with above-normal blood pressure seen at Wayne Health Mobile Health Unit events in Detroit. It combines a retrospective analysis of MHU patients beginning in April 2020 with a prospective sub-cohort who consent to ongoing follow-up through electronic health records and, for a subset, home blood pressure monitoring. Enrolled participants must be 18 or older, have elevated blood pressure (≥120 systolic or ≥80 diastolic), and be able to receive text messages; the protocol includes text-message reminders as part of its intervention tools. The study will analyze clinical data, health care utilization, and social determinants of health to identify drivers of poor blood pressure control and inform targeted prevention strategies.
Why it matters
Potential benefit: If successful, the project could support low-cost, targeted interventions like text reminders and home monitoring that help keep blood pressure controlled and reduce future cardiovascular risk.
How similar studies have gone: Prior programs using text-message reminders and home blood pressure monitoring have shown modest improvements in blood pressure control in various populations, though results depend on community context and access to care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Mobile Health Unit Patients with blood pressure above normal (≥120 systolic and/or ≥80 mmHg) * Has a phone with the ability to receive text messages * 18+ years old * Consent to allow prospective follow-up including through EHR review Exclusion Criteria: * Non-mobile health unit patients * MHU patients with systolic BP \< 120 mmHg AND diastolic BP \< 80 mmHg * Pregnant Women * Children less than 18 years old * Individuals viewed by the investigative team as unable to understand and sign the informed consent form * Currently enrolled in another on-going interventional trial initiated on the mobile health unit
Where it's running
-
Wayne Health Mobile Units
Detroit, Michigan, United States Recruiting
Study contacts
- Principal investigator: Steven J Korzeniewski, PhD — Wayne State University
- Study coordinator: Phillip Levy, MD, MPH
- Email: plevy@med.wayne.edu
- Phone: 313-577-1214
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BPCARE: Community health worker support to improve blood pressure and medication use
This trial will test whether community health workers can help adult refugees with high blood pressure take their medicines and keep their blood pressure under control compared with enhanced usual care.
-
Fast control of resistant high blood pressure in Brazil's public health system
This will see if a single-pill triple combination (perindopril, indapamide, amlodipine) controls blood pressure better than usual separate-pill regimens in adults with apparent resistant hypertension.
-
Improving hypertension care in Ghana and Baltimore
This program tests whether a package of patient-, provider-, and health-system interventions can improve blood pressure control for adults ages 18–70 with hypertension who receive care at participating clinics and own a smartphone.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.